CLBT trades 27.6% below Wall Street's consensus target of $14.13.
Last 12 months price action with 12-month analyst target path
The base valuation assumes CLBT achieves its forward estimates and maintains a stable P/E multiple of 40.1x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of October 3, 2026, Cellebrite DI Ltd. (CLBT) has a Wall Street consensus price target of $14.13, based on estimates from 9 covering analysts. With the stock currently trading at $11.07, this represents a potential upside of +27.6%. The company has a market capitalization of $2.76B.
Analyst price targets range from a low of $12.50 to a high of $15.00, representing a 18% spread in expectations. The median target of $14.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,0 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CLBT trades at a trailing P/E of 35.7x and forward P/E of 40.1x. Analysts expect EPS to grow +18.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $11.27, with bear and bull scenarios of $7.10 and $14.84 respectively. Model confidence stands at 63/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AXONAxon Enterprise, Inc. | $33.3B | $413.35 | $652.14 | +57.8% | Buy | 53.7x | 22 |
 VRNSVaronis Systems, Inc. | $5.5B | $47.57 | $49.75 | +4.6% | Buy | 318.4x | 35 |
 OSPNOneSpan Inc. | $672M | $18.12 | $16.00 | -11.7% | Buy | 14.6x | 15 |
 NTCTNetScout Systems, Inc. | $3.0B | $40.96 | $43.00 | +5.0% | Hold | 17.0x | 21 |
 IIIVi3 Verticals, Inc. | $341M | $14.28 | $26.00 | +82.1% | Buy | 13.3x | 15 |
 SPSCSPS Commerce, Inc. | $3.0B | $82.35 | $69.00 | -16.2% | Hold | 16.8x | 23 |
 CACICACI International Inc | $13.6B | $615.04 | $722.67 | +17.5% | Buy | 21.8x | 29 |
 SAICScience Applications International Corporation | $5.3B | $125.26 | $118.75 | -5.2% | Hold | 12.4x | 18 |
 LDOSLeidos Holdings, Inc. | $14.8B | $117.74 | $152.75 | +29.7% | Buy | 9.9x | 28 |
 BAHBooz Allen Hamilton Holding Corporation | $8.1B | $67.35 | $89.00 | +32.1% | Buy | 11.1x | 22 |
Quick answers to the most common questions about buying CLBT stock.
The consensus Wall Street price target for CLBT is $14.13, representing 27.6% upside from the current price of $11.07. With 9 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
CLBT has a consensus rating of "Buy" based on 9 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $14.13 implies 27.6% upside from current levels.
At a forward P/E of 40.1232x, CLBT trades at a premium valuation. The consensus price target of $14.13 (27.6% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $15 for CLBT, while the most conservative target is $12.5. The consensus of $14.13 represents the median expectation. Our quantitative valuation model projects a bull case target of $15 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CLBT is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 0 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CLBT stock forecast based on 9 Wall Street analysts shows a consensus price target of $14.13, with estimates ranging from $12.5 (bear case) to $15 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $11, with bear/bull scenarios of $7/$15.
Our quantitative valuation model calculates CLBT's fair value at $11 (base case), with a bear case of $7 and bull case of $15. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 63/100.
CLBT trades at a forward P/E ratio of 40.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 35.7x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on CLBT, with a "Buy" consensus rating and $14.13 price target (27.6% upside). 9 of 9 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CLBT analyst price targets range from $12.5 to $15, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14.13 consensus represents the middle ground. Our model's $7-$15 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.